Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, ...
In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...
Dawe, PhD, as Scientific Advisor, Neuropharmacology & Translational Neuroscience, and Tomi K. Sawyer, PhD, as Strategic ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, developed a technology based on quantum key distribution protocol and quantum random number ...
The East Asian Subtropical Westerly Jet (EASWJ) and the East Asian Summer Monsoon (EASM) are two pivotal components of the ...
Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...
Rising carbon dioxide (CO2) emissions from human activities are the largest contributor to global warming. According to the ...
The MarketWatch News Department was not involved in the creation of this content.-- FB301 was safe and well tolerated in healthy female subjects, with all primary and secondary en ...
A new report published this week outlines further details of Apple’s plan to combat the crease. According to TrendForce, two ...
HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced the preclinical poster presentation titled, ...
Leucine-rich repeat-containing 8A (LRRC8A) is a ubiquitously expressed transmembrane protein that functions as the essential ...
A new study demonstrated a brain-computer interface technology that enables spinal cord injury patients to walk with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results